Department of Human Neurosciences, Sapienza University of Rome
Roma, RM, 00185, Italy
NCT Number: NCT04110106
This study aim to evaluate the correlation between Quality of Life (QoL) and severity of Parkinson's Disease (PD) by assessing the presence of an optimal cut-off point on the Parkinson's disease questionnaire (PDQ-39) as related to the Hoehn & Yahr (H&Y) scale in a cohort of Italian adults with PD.
A multicenter, cross-sectional study was performed in central and northern Italy. This study was conducted on a cohort of consecutive individuals at three neurologic outpatient clinics. All participants were evaluated with the PDQ-39, and the severity of PD was recorded according to the H&Y scale by a neurologist. Receiver operating characteristic (ROC) curves and coordinates of the curve, which were visually inspected, were used to find cut-off points with optimal sensitivity and specificity. These were in turn used to determine the optimal PDQ-39 cut-off score for identifying disease severity according to H&Y stages.
Looking for future studies?
Notify Me50 year–90 year
All sexes
Observational
Roma, RM, 00185, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All participants were evaluated with the PDQ-39, and the severity of PD was recorded according to the H&Y scale by a neurologist.
Time frame: at admission to the neurologic outpatient clinics
severity of Parkinson's disease
Time frame: at admission to the neurologic outpatient clinics
quality of life
R.O.M.A. - Rehabilitation & Outcome Measures Assessment
Other
Correlation Between Quality of Life and Severity of Parkinson's Disease by Assessing an Optimal Cut-off Point on the Parkinson's Disease Questionnaire (PDQ-39) as Related to the Hoehn & Yahr (H&Y) Scale
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06230926
Basal Ganglia Diseases, Brain Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05538455
Alzheimer Disease, Basal Ganglia Diseases
Milan, MI, Italy
View Trial DetailsNCT04215900
Basal Ganglia Diseases, Brain Diseases
Coral Gables, Florida, United States
View Trial DetailsNCT04928833
Balance, Basal Ganglia Diseases
Güneysu, Rize Province, Turkey (Türkiye)
View Trial Details